These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18053089)
1. NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression. Baugé C; Beauchef G; Leclercq S; Kim SJ; Pujol JP; Galéra P; Boumédiene K J Cell Mol Med; 2008; 12(5A):1754-66. PubMed ID: 18053089 [TBL] [Abstract][Full Text] [Related]
2. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes. Chadjichristos C; Ghayor C; Kypriotou M; Martin G; Renard E; Ala-Kokko L; Suske G; de Crombrugghe B; Pujol JP; Galéra P J Biol Chem; 2003 Oct; 278(41):39762-72. PubMed ID: 12888570 [TBL] [Abstract][Full Text] [Related]
3. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. Porée B; Kypriotou M; Chadjichristos C; Beauchef G; Renard E; Legendre F; Melin M; Gueret S; Hartmann DJ; Malléin-Gerin F; Pujol JP; Boumediene K; Galéra P J Biol Chem; 2008 Feb; 283(8):4850-65. PubMed ID: 18065760 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. Chadjichristos C; Ghayor C; Herrouin JF; Ala-Kokko L; Suske G; Pujol JP; Galéra P J Biol Chem; 2002 Nov; 277(46):43903-17. PubMed ID: 12186868 [TBL] [Abstract][Full Text] [Related]
6. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines. Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617 [TBL] [Abstract][Full Text] [Related]
7. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells. Liu Y; Zhong X; Li W; Brattain MG; Banerji SS J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860 [TBL] [Abstract][Full Text] [Related]
8. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Zhao S; Venkatasubbarao K; Li S; Freeman JW Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts. Chang W; Parra M; Ji C; Liu Y; Eickelberg O; McCarthy TL; Centrella M Gene; 2002 Oct; 299(1-2):65-77. PubMed ID: 12459253 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes. Baugé C; Attia J; Leclercq S; Pujol JP; Galéra P; Boumédiene K Arthritis Rheum; 2008 Jan; 58(1):221-6. PubMed ID: 18163503 [TBL] [Abstract][Full Text] [Related]
12. Ultraviolet irradiation represses TGF-β type II receptor transcription through a 38-bp sequence in the proximal promoter in human skin fibroblasts. He T; Quan T; Fisher GJ Exp Dermatol; 2014 Oct; 23 Suppl 1(0 1):2-6. PubMed ID: 25234828 [TBL] [Abstract][Full Text] [Related]
13. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro. Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation. Hypes MK; Pirisi L; Creek KE Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999 [TBL] [Abstract][Full Text] [Related]
15. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells. Liu J; Yang H; Liu W; Cao X; Feng X J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479 [TBL] [Abstract][Full Text] [Related]
16. Xylosyltransferase-1 expression is refractory to inhibition by the inflammatory cytokines tumor necrosis factor α and IL-1β in nucleus pulposus cells: novel regulation by AP-1, Sp1, and Sp3. Ye W; Zhou J; Markova DZ; Tian Y; Li J; Anderson DG; Shapiro IM; Risbud MV Am J Pathol; 2015 Feb; 185(2):485-95. PubMed ID: 25476526 [TBL] [Abstract][Full Text] [Related]
17. Sp3 Transcription Factor Cooperates with the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein To Synergistically Activate Specific Viral and Cellular Gene Promoters. Chen LY; Chen LW; Peng KT; Hung CH; Chang PJ; Wang SS J Virol; 2020 Aug; 94(18):. PubMed ID: 32641483 [TBL] [Abstract][Full Text] [Related]
18. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II. Song K; Wang H; Krebs TL; Kim SJ; Danielpour D Cancer Res; 2008 Oct; 68(19):8173-82. PubMed ID: 18829577 [TBL] [Abstract][Full Text] [Related]
19. Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor. Ji C; Casinghino S; McCarthy TL; Centrella M J Biol Chem; 1997 Aug; 272(34):21260-7. PubMed ID: 9261136 [TBL] [Abstract][Full Text] [Related]
20. Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine oxidase (MAO) B gene. Ou XM; Chen K; Shih JC J Biol Chem; 2004 May; 279(20):21021-8. PubMed ID: 15024015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]